Xponance Inc. Sells 2,995 Shares of Albertsons Companies, Inc. (NYSE:ACI)

Xponance Inc. decreased its position in shares of Albertsons Companies, Inc. (NYSE:ACI) by 8.5% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 32,114 shares of the company’s stock after selling 2,995 shares during the period. Xponance Inc.’s holdings in Albertsons Companies were worth $634,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of ACI. Geneos Wealth Management Inc. bought a new position in Albertsons Companies in the 1st quarter valued at $41,000. Signaturefd LLC raised its holdings in shares of Albertsons Companies by 108.4% in the second quarter. Signaturefd LLC now owns 2,365 shares of the company’s stock valued at $47,000 after buying an additional 1,230 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Albertsons Companies by 2,948.4% in the second quarter. Blue Trust Inc. now owns 2,896 shares of the company’s stock valued at $62,000 after buying an additional 2,801 shares during the last quarter. UniSuper Management Pty Ltd lifted its position in Albertsons Companies by 133.3% during the 1st quarter. UniSuper Management Pty Ltd now owns 4,900 shares of the company’s stock worth $105,000 after buying an additional 2,800 shares in the last quarter. Finally, Intact Investment Management Inc. bought a new stake in Albertsons Companies during the 2nd quarter worth about $126,000. 71.35% of the stock is owned by institutional investors and hedge funds.

Albertsons Companies Stock Performance

Albertsons Companies stock opened at $18.49 on Monday. Albertsons Companies, Inc. has a 1 year low of $17.80 and a 1 year high of $23.47. The company’s 50-day moving average is $19.55 and its two-hundred day moving average is $20.09. The company has a current ratio of 0.88, a quick ratio of 0.21 and a debt-to-equity ratio of 2.67. The company has a market cap of $10.71 billion, a PE ratio of 8.29, a PEG ratio of 1.02 and a beta of 0.49.

Albertsons Companies (NYSE:ACI) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.01). Albertsons Companies had a net margin of 1.41% and a return on equity of 56.01%. The business had revenue of $24.27 billion during the quarter, compared to the consensus estimate of $24.16 billion. During the same period in the previous year, the business posted $0.89 earnings per share. Albertsons Companies’s revenue was up .9% compared to the same quarter last year. Equities analysts anticipate that Albertsons Companies, Inc. will post 2.26 earnings per share for the current year.

Albertsons Companies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 9th. Investors of record on Friday, July 26th were paid a dividend of $0.12 per share. The ex-dividend date was Friday, July 26th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.60%. Albertsons Companies’s dividend payout ratio (DPR) is presently 21.52%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on ACI shares. Melius Research started coverage on shares of Albertsons Companies in a research note on Monday, September 23rd. They issued a “hold” rating and a $19.00 target price for the company. Telsey Advisory Group restated a “market perform” rating and issued a $27.25 price objective on shares of Albertsons Companies in a research report on Thursday, July 18th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $23.54.

Albertsons Companies Profile

Albertsons Companies, Inc, through its subsidiaries, engages in the operation of food and drug stores in the United States. The company’s food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services. It also manufactures and processes food products for sale in stores.